Abbreviations
ATP: Adenosine triphosphate
Cyclic AMP: 3’,5’-adenosine
mono-phosphate
GFR: Glomerular filtration rate
PTE:
Parathyroid extractPTH: Parathyroid hormone
%
TRP: Percent tubular reabsorption14
NEWBORN
URINARY
CYCLIC
AMP
AND
DEVELOPMENTAL
RENAL
RESPONSIVENESS
TO
PARATHYROID
HORMONE
Louie G. Linarelli, M.D., with the technical assistance of John Bobik and Caroline Bobik, B.S.
From the Department of Pediatrics, Mercy Hoital and Children’s Hospital of the
University of Pittsburgh
ABSTRACT. Since the renal action of parathyroid hormone is known to be mediated via
3’,5’-adeno-sine monophosphate (cyclic AMP), urinary cyclic AMP studies were used to determine proximal
tubular maturation. Ten formula fed full-term male infants showed a thirty- to sixtyfold increase
in phosphate clearance and excretion with a
three- to fourfold increase in urinary cyclic AMP
comparing their first and third day 24-hour urines (2.37 ± 0.41 to 6.93 ± 0.96 Nm/mg creatinine M. ± S.E.M. first and third days respectively).
Seven breast-fed infants showed cyclic AMP
ex-cretion of 3.6 ± 0.3 S.E.M. and 6.5 ± 0.3 S.E.M.
on Day 1 and Day 3 respectively, showing an in-significant difference to the formula-fed infants. An additional 10 formula-fed infants 5 to 10 days
of age excreted 7.0 ± 0.9 S.E.M. Nm/mg of
creatinine which is comparable to the 3 to 4 days
of age group. The threefold increase in cyclic
AMP after the first day of life may possibly
re-flect increasing parathyroid renal responsiveness.
One- and 3-day-old infants and adults were given a 1-hour parathyroid (PTH) infusion (5 U/kg/hr) with measurement of urinary cyclic AMP in time periods before and after the infusions. Peak in-creases in responses from baseline of cyclic AMP were 1.64 ± 0.34 ,7.1 ± 1.5, and 36.0 ± 0.73 Nm/
mg of creatinine M. ± range on first day, third day, and in adults respectively with similar relationships
of increasing phosphate excretion. Thus, there is
most likely a maturational renal proximal tubular
re-sponsiveness to PTH on the cellular cyclic AMP
level.
Pediatrics, 49:14, 1972, NEWBORN KIDNEY, PARA-THYROID HORMONE, CYCLIC AMP, RENAL DEvELoP-MENT.
E
VU)ENCE from numerous investigatorshas shown that adenosine 3’,5’
mono-phosphate (cyclic AMP) is the intracellular mediator of the action of most hormones.l,2
In 1962, Butcher and Suther1and
demon-strated the presence of cyclic AMP in
hu-man urine. In 1967, Chase and Aurbach4
found that urinary cyclic AMP rose in
re-sponse to parathyroid hormone (PTH) in
human studies. They also demonstrated
that PTH acts by stimulating the
particu-late membrane enzyme adenyl cyclase in
both kidney proximal tubules5’#{176} and bones.7
The urinary cyclic AMP excretion in
re-sponse to PTH is renal in origin8 and cyclic
AMP has also been shown to mediate the
phosphaturic effect of PTH.9 Our studies
have been performed to compare the
excre-tion of phosphate and cyclic AMP in the
urine of newborn infants and to evaluate
the phosphaturic and cyclic AMP
respon-siveness to PTH in the first 3 days of life.
MATERIALS AND METHODS
Ten full-term male infants and seven
breast-fed infants at Mercy Hospital
nur-sery, Pittsburgh, Pennsylvania, were
se-lected for collections of 24-hour urines. Males were selected in order to insure more (Received August 16, 1971; revision accepted for publication January 13, 1972.)
Supported by Health Research and Services Foundation M-30.
ADDRESS FOR REPRINTS: (L.G.L.) Department of Pediatrics, Mercy Hospital, Pride and Locust Street, Pittsburgh, Pennsylvania 15219.
complete urine collections. At birth, follow-ing the first voided specimen, these infants were strapped with urine collecting devices for the first 24-hour urine (Day 1). Bloods
were drawn by heel stick at approximately midpoint of each 24-hour urine for calcium,
phosphate, and creatinine. The second
24-hour urine collections (Day 3) were started
between 48 and 72 hours of life to avoid
night-time blood specimens. Infants were
fasted for the first 12 hours of life then
given a glucose water feeding followed by
formula (Enfamil* ) every four hours. Parathyroid extract (PTEt ) at a dose of 5
U/kg in 1 hour (83 mU/kg/mm) was
given intravenously to two infants in the
first 24 hours and on the third to fourth day.
Three adolescent subjects were also given 5
U/kg/hr PTE infusions for 1 hour.
Intra-venous hydration of 20 cc/kg was given in
the first 60 to 120 minutes to initiate urine flow and obtain control urine collections.
Then PTE 5 U/kg with 0.5% albumin in
5% glucose was given over 1 hour.
Hydra-tion was maintained with drinking water
and intravenous 0.45% sodium chloride.
Urine collected in time periods before and
after intravenous PTE were collected for
measurements of phosphate, creatinine, and
0 Mead-Johnson Company, 2404 W.
Pennsylva-nia Street, Evansville, Indiana 47721.
t Eli Lilly Company, 307 E. McCarthy,
In-dianapolis, Indiana 46206.
TABLE I
NEWBORN 24-HouR URINARY PHOSPHATE AND CYCLIC AMP
. Patient . Weight (gm) S.A. M2 Day of Life Volume (ml) Urine Cr my/e’4 hr/
Pho$phale Cycli #{149}.AMP
L Vp mg/fl Sri
j73%J2
-L I p mg/kq/ ?ihr Cp #{149} nzl/intn/ 1.73Af’ Total Nm Nmoles/ , m2Cr Nmoles/ . mm Nmote8/ , i.,SM2
IN. ,69S 0.178 1 5 10.5 4.SO 0.93 OlO 53 5.04 004 515
S 110 3.O 35.8O 13.48 l8 197 6.15 0.14 1,915
11.U. 8,600 O.5 I
S 100 9.O 39.4 5.76 844.00 O.si 30.55 0.06 6.31 96 419 3.31 1O.6 0.07 Ol9 737 3l18
RE. 3,430 O.QO I 110 i8.8 8.55 0.13 0.06 53 1.84 0.04 417
3 180 30.6 I3.6O 7.9 1.65 l1 6.88 0.15 1,658
LO. 3.884 O.3O 1
3 18 175 iO.O 70.1 2.84 5l6.4O 0.10 18.04 0.03 3.93 9 54 0.45 0.77 0.01 0.04 68 406
K.A. 3,090 0Z00 I 7 18.9 4.67 0.18 0.05 53 .80 0.04 438
3 135 .9 3l5l9 11.79 .81 134 5.84 0.09 1,159
AL.. 3,033 0.Q30 I
3 3 220 31.9 41.7 il.i4 777.36 0.93 34.09 0.6 7.50 39 405 1l2 9.69 0.03 0.28 293 3,045
HO. 2,892 0.190 1
S 13 133 6.0 21.6 8.28 20.70 0.31 7.70 0.18 1.60 16 231 9.68 10.69 0.01 0.16 145 2,102
JO. 3,572 0.210 1 92 41.4 3.03 0.10 0.04 124 2.99 0.09 1,022
3 iSO 26.0 299.94 10.19 2.51 134 5.15 0.09 1,104
S.C. 3,515 0.210 1 35 26.6 1.73 0.06 0.02 53 1.99 0.04 437
3 128 19.1 673.28 13.47 3.66 158 8.23 0.73 1,302
ST. 2,948 0.188 1 88 26.7 3.24 0.12 0.03 36 1.35 0.01 331
3 225 26.9 227.70 8.40 2.66 143 5.30 0.10 1,315
PHOSPHATE EXCRETiON mg/24 hrs./1.73 M2
Fic. 1. Values for phosphate measurements from urines collected on Day 1 and Day 3 of life from 10 formula-fed full-term male infants. Complete data are tabulated in Table I. Urine phosphate
ex-cretion mg/24 hr/1.73 M2.
I
E
E
S. U
PHOSPHATE CLEARANCE
ml/min.,/ l.73M’
Fic. 2. Values for phosphate measurements from
urines collected on Day 1 and Day 3 of life from
10 formula-fed full-term male infants. Complete
data are tabulated in Table I. Phosphate clearance ml/min/1.73 M2.
cyclic AMP. Blood samples were drawn at
near midpoints of urine collections for
phosphate and creatinine.
Urine specimens were frozen until
ana-lyzed. Blood specimens were centrifuged
and analyzed immediately. Adenosine
3’,5’-monophosphate was determined by the
method of Kaneko and Field’#{176} where
cyclic AMP is converted to ATP, and ATP
is assayed by measuring the quantity of
‘4C02 evolved from glucosel-.1 4C. Isolation
of urinary cyclic AMP prior to assay was
performed as described by Chase, et al.hi
RESULTS
Data on urines collected on Day 1 and
Day 3 of life from 10 formula-fed full-term male infants is shown in Table I. The phos-phate excretion increases by fiftyfold with a
mean of 7.8 mg/24 hr/1.73 M2 on Day 1 to
231.4 mg/24 hr/1.73 M2 on Day 3 (Fig.
1). Likewise, there was a thirty- to forty-fold increase in phosphate clearance by the
third day (Fig. 2) with a mean of 0.09 ml
/min/1.73 M2 on Day 1 to 3.49 ml/min/
1.73 M2 on Day 3. There was a tendency for
the serum calcium to drop and phosphate
to rise by the third day of life, but the dif-ference was insignificant.
Twenty-four-hour urine cyclic AMP was
measured in these same 10 formula-fed
in-fants. Cyclic AMP rises from a mean of 53
Nm/24 hours to 209 Nm/24 hours
URINARY CYCLIC AMP
N MoI../24 hr..
4w
4S
3$
341 #{163}
I
ii
41
the fourfold increase in urine output, there
was a threefold increase in cyclic AMP
ex-cretion expressed as Nm/mg of creatinine.
The means are 2.37 and 6.9 Nm/mg of
creatinine on Day 1 versus Day 3
respec-tively ( Fig. 4)
.
Since it is extremely diffi-cult to insure accurate 24-hour urine collec-tions in newborn infants, errors in timing ofcollections are minimized by relating the
data to creatinine excretion. There was a
tendency for the cyclic AMP excretion to
follow the phosphate excretion in many
cases but there was a lack of linear
correla-tion between the two functions. For
exam-pie, number seven was the lowest
phos-phate excretor and one of the highest cyclic AMP excretors.
Urines were collected for cyclic AMP
analysis on seven breast-fed infants on Day 1 versus Day 3. The cyclic AMP excretions were 3.6 ± 0.3 S.E.M. and 6.5 ± 0.3 S.E.M.
Nm/mg of creatinine on Day 1 and Day 3
respectively, giving an insignificant differ-ence in the formula-fed versus the
breast-fed infants. Ten formula-fed infants 5 to
10 days of age excreted 7.0 ± 0.9 S.E.M.
Nm/mg of creatinine which is a
compara-ble excretion to the 3 to 4 day age group.
Table II compares newborn infants
ver-sus adult urinary cyclic AMP excretion in
our laboratory. The cyclic AMP excretion
expressed in Nm/24 hr/1.73 M.2 on Day 1
is 442 and on Day 3 is 1,722 compared with an adult level of 4,162. The higher value in adults reflects in part the relatively greater surface area of the neonate. Average values
of 2.3 Nm/mg creatinine on Day 1
com-pared to 6.9 Nm/mg creatinine on Day 3 are
obviously significantly different. However, adult values are slightly greater than those on Day 1 (0.02 <p <0.05). Because of low glomerular filtration rate (GFR) in infants, the cyclic AMP values corrected for
creati-nine excretion are in part increased relative
to the adult values.
To test renal responsiveness to
parathy-roid hormone, parathyroid extract (PTE)
was infused intravenously at 5 U/kg for 1
hour (83 mU/kg/mm). It has previously
been shown in adult volunteers that an
in-0*81 0*83
Fm. 3. Values for cyclic AMP measurements from urines collected on Day 1 and Day 3 of life from 10 formula-fed full-term male infants. Complete data are tabulated in Table I. Urinary cyclic AMP N
moles/24 hours.
fusion of 80 mU/kg/mm of PTH produced
the maximum response of cyclic AMP
ex-cretion.8 Urines were collected at time
in-tervals before, during, and following PTE
infusion. These infusions were performed in infants the first 24 hours of age, 3 to 4 days
of age (Table III), and adolescent adult
volunteers 16 to 18 years of age (Table
IV). Figure 5 shows the delta from
base-line of phosphate studies before PTE infu-sion to peak rise which occurred in the first
2 hours after PTE infusion. Delta
phos-phate excretion expressed in milligrams per
hour is near 0 on Day 1, 8.9 on Day 3, and
31.5 in the adolescent adult. Phosphate
clearance expressed in millimeters per min-ute is 0 Day 1, 1.69 on Day 3, and 13.07 in the adults. The delta percent tubular
reab-sorption (%TRP) did not show a clear
dis-tinction in the Day 3 infant versus adults.
Control %TRP in these newborn infants
sim-I,
r
z
0*83
Ftc. 4. Values for cyclic AMP measurements from
urines collected on Day 1 and Day 3 of life from
formula-fed full-term male infants. Complete data
are tabulated in Table I. Urinary cyclic AMP N
moles/mg creatinine. 0*81
PTE INFUSION
Ezcrstlon CIsr.nc.
I
Fm. 5. Comparison of change in phosphate ex-cretion, phosphate clearance, and %TRP follow-ing parathyroid extract infusion at a dosage of 5 U/kg over 1 hour in 1- and 3-day-old infants
versus adults.
12 URINARY C’VCLIC AMP ilar to previous observations.12 Peak
in-N Mal../w4 Crs.ilnin. creases from baseline cyclic AMP in the
same patients revealed deltas of 1.64 ± 0.34
41 Nm/mg of creatinine on Day 1, 7.15 ± 1.15
on Day 3, and 36.3 ± 0.73 in the adolescent adult (Fig. 6).
DISCUSSION
Phosphate excretion and clearance has
previously been found to rise significantly
between 1 and 3 days of age.3 Our data
show a similar trend in rates of daily
excre-tion between cyclic AMP and phosphate
but with no clear linear correlation between
these two functions in the individual
for-mula-fed infants. Likewise, cyclic AMP
ex-cretion in breast-fed and formula-fed infants
is comparable even though it is known
that phosphate excretion is less in breast-fed infants.l4,hi However, a direct linear
correlation between phosphate and cyclic
-
AMP excretion due to changes in PTHse-cretion would not necessarily be expected since at least in adults the maximum
phos-phaturic response to PTH is at a much
lower dose (10 mU/kg/mm) than the cyclic
AMP response which was still rising at the
highest dose employed at 80 mU/mm/kg. 3H cyclic AMP studies1#{176} in human adult T.LR
volunteers has shown that cyclic AMP is
: cleared by glomerular filtration at the same
rate as inulin but that the clearance exceeds
inulin clearance with a cyclic AMP/inulin
ratio of 1.5. This information implies that
two-thirds of the urinary cyclic AMP is
de-rived from the plasma circulation or GFR,
and one-third is released directly into the urine from the kidney. With this in mind, investigators have demonstrated a tendency
for increased cyclic AMP excretion in
hy-perparathyroid patients and decreased
ex-cretion in hypoparathyroid patients.8’17
TABLE II
COMPARISON OF NEWBORN AND ADULT URINARY
CYCLIC AMP
TABLE III
to 5.0 Nm of cyclic AMP/mg creatinine,
which is in the range of Day 1 infants, and the hyperparathyroid patients have excreted
as high as 12 Nm/mg creatinine with an
average of near 7 Nm/mg creatinine which
is comparable to the level in our 3 to 10
days of age infants.
The increasing cyclic AMP excretion
with age in infants is compatible with
in-creasing parathyroid activity and/or
in-creasing renal responsiveness to PTH but
this could be explained by other factors
than effects of phosphate intake and
cellu-lar maturation. Plasma cyclic AMP levels
and 3H cyclic AMP studies have not been
measured in infants so that the proportion of
urinary cyclic AMP contributed to by
clear-Cyclic AMP
Day 1 (10)
(mean ±
S.E.M.)
Day 3 (10)
(mean ±
S.E.M.)
Adult (14)
(mean ±
S.E.M.)
Nm/24 hr 53 ± 11 209 ±37
Nm/1.73M2 442±88 1,722±277 4,162±476 Nm/mgCr 2.37±0.41 6.93±0.96 3.62±0.41
ance and tubular excretion may be different
with maturation. There are other reasons
that can also be advanced for the increase
in the 24 hour cyclic AMP excretion. Both
glucagon and epinephrine have been noted
EFFEcrS OF PARATHYROID EXTRACT (PTE) INFUSION ON NEWBORN RENAL EXCRETION
OF PHOSPHATE AND CYCLIC AMP
.
Subject Period. Time.
(mm)
Phosphale Cyclic AMP
UVp mg/hr
-Cp % N/ Nm/mg
mi/mm TRP mm Cr
M.A. 1 150 0.05 0.13 99.6 0.09 3.92
A. Day 1
3,345gm
18 hours old 2
3
95
105
0.06
0.05
PTE 5 U/kg over next 60 mm
0.19 99.4 0.06 5.22
0.14 99.3 0.13 4.42
4 150 0.04 0.11 95.1 0.09 2.86
C.O. 1 45 0.04 0.11 99.3 0.07 3.48
B. Day 1
3,374gm
20hoursold
2
3
55
125
0.04
0.01
PTE 5 U/kg over next 60 mm
0.10 99.5 0.13 5.46
0.02 99.8 0.12 4.12
C.O. 1 105 2.32 0.52 76.3 0.08 6.35
B. Day3 2 50 3.35 0.75 75.4 0.16 8.84
3,374 gm
72hoursold 3 107 6.20
PTE 5 U/kg over next 60 mm
1.29 61.6 0.30 14.66 4 68 7.38 1.01 58.8 0.21 14.30
5 225 1.97 0.41 81.9 0.13 9.73
L.A. 1 166 2.05 0.54 89.4 0.35 11.60
C. Day 3
5,227gm
84 hours old 2
3
34
93
15.31
8.97
PTE 5 U/kg over next 60 mm
8.27 52.3 0.60 13.70
1.92 71.5 0.60 17.60
20
TABLE IV
EFFECTS OF PARATHYROID EXTRACT (PTE) INFUSION ON ADULT RENAL EXCRETION
OF PHOSPHATE AND CYCLIC AMP
.
Subject Period. Time.
(nun)
Phosphale Cyclic AMP
UVp
mg/hr
Cp % Nm/mm
mi/mm TRP Nm/mg Cr R.R. 1 2 65 60 7.9 28.1
8.16 97.1 2.9
11.15 91.0 6.3
2.87 5.63 3 4 5 60 60 60 52.0 64.0 4.0
PTE 5 U/kg over next 60 mmn
28.57 50.3 47.0
25.40 96.7 9.0 1.58 98.1 3.0
38.90 8.59 3.71 B.H. 1 2 60 60 4.03 13.20
2.24 97.9 5.6
7.34 94.1 3.1
3.42 2.46 3 4 5 6 43 22 74 66 7.45 30.19 30.65 16.81
PTE 5 U/kg over next 60 mm
5.31 93.0 10.9
16.77 88.0 46.4
15.00 86.8 7.4 8.35 93.6 3.9
14.51 37.85 8.63 5.46 A.B. 1 2 65 65 19.90 17.02
8.96 93.6 1.7
7.60 95.0 4.3
3.71 6.16 3 4 5 60 60 60 37.92 21.96 10.56
PTE 5 U/kg over next 60 mm
16.60 50.0 31.0
8.10 91.3 1.0
4.40 88.0 3.0
39.72
2.64
5.35
to cause increased urinary cyclic AMP
ex-cretion.18 Elevated cord blood and plasma
newborn glucagon-like activity have been
found in infantslO and could certainly play
a role in increased cyclic AMP excretion of
neonates. Even though newborn infants are
fully capable of producing
catechola-mines,20’2’ epinephrine is a weak stimulus to
cyclic AMP excretion.18 The GFR of
new-born infants with early cord clamping is
20.3 ± 1.2 ml/min/1.73 M2 (M ± S.E.M.)
at 1 to 12 hours of life compared to
33.0 ± 3.6 at 2 to 5 days of age.22 This
in-creasing GFR could in part explain
increas-ing cyclic AMP but would not explain adult levels at 1 day and high levels at 3 days of age.
Classical tetany of the newborn occurs
between 5 and 10 days of life and is more
prevalent in infants fed cow’s milk which
has the highest phosphorus content
(cow’s milk 96 mg/100 ml; Enfamil
for-mula 45 mg/100 ml; human milk 15 mg/
100 ml) and a low calcium-phosphorus
ratio (Cow’s milk 1.3; Enfamil 1.3; Human
2.2).1415 Insufficient PTH to induce
phos-phate diuresis to correct
hyperphosphate-mia or “transient hypoparathyroidism” was
postulated as early as 1936 to explain the
resultant hypocalcemia.23 One possible
mechanism involved is that milk feeding
with its phosphate load and subsequent low-ering of serum calcium is a physiologic
mechanism for challenging the
ITS. INFUSION
z
S.
0*81 0*134 *011.8
Fm. 6. Comparison of urinary cyclic AMP
ex-cretion in control urine to peak rise following
parathyroid extract infusion in the same patients
as Figure 5. The complete data are tabulated in Tables III and IV.
is an abrupt hyperphosphatemia with slight
hypocalcemia and a significant abrupt rise
in plasma parathyroid hormone within an
hour.’ Likewise, one possible interpreta-tion of our data showing increasing urinary
cyclic AMP/creatinine between the first
and third day of life is that there may be
increasing PTH secretion and/or
increas-ing renal responsiveness to PTH. Previously it had been shown that the fraction of fil-tered phosphate excreted by cow’s milk-fed
infants was higher than adults and did not
differ between normal infants or infants
with tetany leading McCrory, et aL25 to sug-gest inadequate compensatory
hyperpara-thyroidism rather than absolute hypopara-thyroidism. This is consistent with the
para-thyroid hyperplasia found in newborn
in-fants receiving cow’s milk.26’27 However,
there has been disagreement on the PTH
levels in newborn infants. PTH levels in
matched maternal-cord blood samples have
been shown both to be higher28 and lower in cord blood29 by different investigators.
Root, et al.29 finds the cord blood PTH
lower than maternal levels, and it remains lower in the first 72 hours of life.
Measure-ment of PTH levels beyond 72 hours of life
has not been reported. Kaplan26 noted the
parathyroid hyperplasia in the cow’s milk-fed infants between 3 to 10 days of life and
this hyperplasia was not present before 72
hours of life. Thus, it is uncertain whether
this hyperplasia means increasing PTH
se-cretion or is just an attempt to meet the
de-mands for PTH.
Connelly, et al.13 demonstrated a change
in the phosphaturic response to PTH with
aging by administering intramuscular PTH
on the first and third day of life. Since
PTH-induced phosphaturia is most likely
by renal cyclic AMP,8’9 our studies suggest that the maturational phosphaturic response to PTH is secondary to the maturational
cyclic AMP response to PTH. We were
unable to demonstrate a phosphaturic
response on the first day of life with
intra-venous PTH in our two patients but
Con-nellyl3 showed some responsiveness with
twice the dose intramuscularly with 24-hour
EJs.far.
c...
Alurine collections. Further studies to
deter-mine when in infancy the cyclic AMP
re-sponse to PTH is comparable to adult
re-sponse are being conducted in our
labora-tory. McCrory, et al.25 has suggested by
studying phosphate excretion that
adult-like response occurs by 7 to 12 days of age. It is hypothesized that this diminished
re-sponsiveness may play a role along with
other factors such as low GFR in the
etiol-ogy of hyperphosphatemia and
hypocalce-mia of newborn infants.
Maturation of renal cortex adenyl cyclase in human neonates to explain the increasing
cyclic AMP responsiveness to PTH has not
been reported. There is a clinical entity
with a deficient renal cyclic AMP response
to PTH for which the underlying cellular
defect is unknown. Pseudohypoparathy-roidism is a clinical hypoparathyroid state
with normal PTH secretion and a
AMP ti1 ‘ Parathyroid
hormone-sensitive adenyl cyclase from the renal cor-tex of a patient with pseudohypoparathy-roidism has recently been demonstrated
making it unlikely that the primary defect
is either the parathyroid hormone receptor, or of the enzyme adenyl cyclase.3#{176} Broadus,
et al.18 have recently speculated that there
may be active renal tubular secretion of
cyclic AMP. Thus, a deficient transport sys-tem for this nucleotide needs to be searched
for in pseudohypoparathyroid patients and
similar approaches to explain diminished
responsiveness to PTH in the newborn
needs to be explored.
REFERENCES
1. Butcher, R. W., Robison, G. A., Hardinan, J. C.,
and Sutherland, E. W.: The role of cyclic AMP in hormone actions. Advances Enzym.
Regul., 6:357, 1968.
2. Butcher, R. W.: Role of cyclic AMP in hor-mone actions. New Eng. J. Med., 279:1378, 1968.
3. Butcher, R. W., and Sutherland, E. W.: Aden-osine 3’,5’-phosphate in biological materi-als. I. Purification and properties of cyclic 3’,5’-nucleotide phosphodiesterase and use
of this enzyme to characterize adenosine 3’,5’ phosphate in human urine. J. Biol. Chem., 237:1244, 1962.
4. Chase, L. R., and Aurbach, C. D.: Parathyroid function and the renal excretion of
3’,5’-adenylic acid. Proc. Nat. Acad. Sci. U.S.A.,
58:518, 1967.
5. Aurbach, C. D., Potts, J. T., Jr., Chase, L. R.,
and Melson, C. L.: Polypeptide hormones
and calcium metabolism. Ann. Intern. Med.,
70:1243, 1969.
6. Melson, C. L., Chase, L. R., and Aurbach,
C. D.: Parathyroid hormone-sensitive adenyl cyclase in isolated renal tubules. Endocrinol-ogy, 86:511, 1970.
7. Chase, L. R., and Aurbach, C. D.: The effect
of parathyroid hormone on the concentration of adenosine 3’,5’-monophosphate in skeletal tissue in vitro. J. Biol. Chem., 245:1520,
1970.
8. Kaminsky, N. I., Broadus, A. E., Hardman,
J. G., Jones, D. J., Jr., Ball, H., Sutherland, E. W., and Liddle, G. W.: Effects of
para-thyroid hormone on plasma and urinary adenosine 3’,S’-monophosphate in man. J.
Clin. Invest., 49:2387, 1970.
9. Ramussen, H., Pechet, M., and Past, D.: Ef-fect of dibutyryl cyclic adenosine 3’,5’-monophosphate, theophylline, and other
nucleotides upon calcium and phosphate metabolism. J. Clin. Invest., 47: 1843, 1968.
10. Kaneko, T., and Field, J. B. : A method for
determination of 3’,5’-cyclic adenosine mono-phosphate bases on adenosine triphosphate formation.
J.
Lab. Clin. Med., 74:682,1969.
11. Chase, L. R., Melson, C. L., and Aurbach,
C. D. : Pseudohypoparathyroidism:
Defec-live excretion of 3’,5’-AMP in response to parathyroid hormone. J. Clin. Invest., 48: 1832, 1969.
12. Richmond, J. B., Kravitz, H., Segar, W., and Waisman, H. A. : Renal clearance of endoge-nous phosphate in infants and children. Proc. Soc. Exp. Biol. Med., 77:83, 1951. 13. Connelly, J. P., Crawford, J. D., and Watson,
J.: Studies of neonatal hyperphosphatemia.
PEDIATRICS, 30:425, 1962.
14. Gardner, L. I., MacLachlan, E. A., Pick, W.,
Terry, M. L., and Butler, A. M. : Etiologic
factors in tetany of newly born infants.
PE-DIATRICS, 5:228, 1950.
15. Citfieman, I. F., and Pincus, J. B.: Influence of diet on the occurrence of hyperphosphate-mia and hypocalcemia in the newborn in-fant. PEDIATRICS, 8:778, 1951.
16. Broadus, A. E., Kaminsky, N. I., Hardman,
J. C., Sutherland, E. W., and Liddle, C. W.: Kinetic parameters and renal clearances of plasma adenosine 3’,5’-monophosphate in man. J. Clin. Invest., 49:2222, 1970.
17. Taylor, A. L., Davis, B. B., Pawison, C.,
Josimovich, J. B., and Mintz, D. H.:
Fac-tors influencing the urinary excretion of 3’,5’-adenosine monophosphate in humans.
J. Clin. Endocr., 30:316, 1970.
18. Broadus, A. E., Kaminsky, N. I., Northcutt, R. C., Hardman, J. G., Sutherland, E. W., and Liddlle, C. W.: Effects of glucagon on adenosine 3’,S’-monophosphate and guano-sine 3’,5’-monophosphate in human plasma and urine. J. Clin. Invest., 49:2237, 1970. 19. Murthy, D. Y., and Colle, E.: Immunoassay of
glucagonlike activity in infants and children. (Abst.) Pediat. Res., 5:397, 1971.
20. Cheek, D. B., Malinek, M., and Farillon, J. M.:
Plasma adrenaline and noradrenaline in the neonatal period, and infants with respiratory distress syndrome and placental insufficiency.
PEDIATRICS, 41:374, 1963.
21. Creensburg, R. E., and Gardner, L. I.: The ex-cretion of free catecholamines by newborn infants. J. Clin. Endocr. Metab., 20:1207,
1960.
22. Oh, W., Oh, M. A., and Lind, J.: Renal func-tion and blood volume in newborn infant re-lated to placental transfusion. Acta Paediat. Scand., 56:197, 1966.
tetany: Metabolic study. Amer. J. Dis. Child., 51:816, 1936.
24. Reiss, E., Canterbury, J. M., Bercovitz, M. A.,
and Kaplan, E. L.: The role of phosphate in
the secretion of parathyroid hormone in
man. J. Clin. Invest., 49:2146, 1970.
25. McCrory, W. W., Forman, C. W., McNamara,
H., and Barnett, H. L.: Renal excretion of
inorganic phosphate in newborn infants. J.
Clin. Invest., 31:357, 1952.
26. Kaplan, E.: Parathyroid gland in infancy.
Arch. Path., 34:1042, 1942.
27. Gardner, L. I.: Tetany and parathyroid
hyper-plasia in the newborn infant: Influence of
dietary phosphate load. PEDIATRICS, 9:534,
1952.
28. Lequin, R. M., Hackeng, W. H., and
Schop-man, W.: A radioimmunoassay for
parathy-roid hormone in man. II. Measurements of
parathyroid hormone concentrations in
hu-man plasma by means of a radioimmuno-assay for bovine hormone. Acta Endocrinol.,
63:655, 1970.
29. Root, A. W., Hawker, C. D., and Utiger, R.: Personal communications.
30. Marcus, R., Wilber, J. F., and Aurbach, C. D.:
Parathyroid hormone-sensitive adenyl
cy-clase from the renal cortex of a patient with
pseudohypoparathyroidism. J. Clin. Endocr.,
33:537, 1971.
Acknowledgment
We are deeply grateful to Miss Donna Stibel, R.N., head nurse, and the nursing staff of the Nur-sery at Mercy Hospital, Pittsburgh, Pennsylvania.
We wish to thank Dr. Frederic M. Kenny for his
helpful suggestions in reviewing this paper.
JOHN LOCKE (1632-1704) ON THE CHILD’S BED
In his Thoughts concerning Education, John
Locke, the philosopher-physician, gave a Mr.
Edward Clarke of Chipley, near Taunton,
Eng-land, detailed rules for bringing up his son.
Locke’s advice about Mr. Clarke’s son’s bed fol-lows:
Let his Bed be hard, and rather Quilts than
Feathers. Hard Lodging strengthens the Parts;
whereas being buried every Night in Feathers, melts
and dissolves the Body, is often the Cause of
Weak-ness, and the Fore-runner of an early Grave. And,
besides the Stone, which has often its Rise from this
warm Wrapping of the Reins; several other Indis-positions, and that which is the Root of them all, a tender weakly Constitution, is very much owing to
Downe-Becls. Besides, He that is used to hard
Lodg-ing at Home, will not miss his Sleep (where he has
most need of it) in his Travels abroad, for want of his soft Bed, and his Pillows laid in order. And
therefore, I think it would not be amiss, to make his Bed after different Fashions, sometimes lay his
Head higher, sometimes lower, that he may not feel
every little Change he must be sure to meet with,
who is not design’d to lie always in my young
Mas-ter’s Bed at home, and to have his Maid lay all
Things in print, and tuck him in warm. The great
Cordial of Nature is Sleep. He that misses that, will
suffer by it: And he is very fortunate, who can take
his Cordial only in his Mother’s fine Gilt Cup, and
not in a Wooden Dish. He that can sleep soundly,
takes the Cordial: And it matters not, whether it be on a soft Bed, or the hard Boards. ‘Tis Sleep only that is the Thing necessary.1
NOTED B T. E. C., Jn., M.D.
REFERENCE
1. Locke, J.: Thoughts concerning Education, ed.